Find your next paid study

Population Health Research InstituteNCT04743765

~$10 – $1,125

Actual pay is set by the research site.

A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r…

Lymphoma, T-Cell

March Biosciences IncNCT06534060

~$75 – $2,800

Actual pay is set by the research site.

Targeting Cognitive Control to Improve Physical Activity Adherence in Midlife for Alzheimer's Risk Reduction

This trial is designed to develop and test the efficacy of cognitive training strategies to improve self-regulatory capacities for middle-aged adults to adopt …

Physical Inactivity

University of IowaNCT06338774

Actual pay is set by the research site.

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Previous studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be w…

Myeloid Malignancy

Henry Ford Health SystemNCT03850418

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Participant- and Investigator--Blinded, Placebo- Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

The purpose of this first-in-human (FIH) study is to evaluate safety, tolerability, pharmacokinetic (PK) of OJR520.

Chronic Kidney Disease

Novartis PharmaceuticalsNCT07235059

~$500 – $10,500

Actual pay is set by the research site.

Catecholaminergic Polymorphic Ventricular Tachycardia

A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia

This is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability,…

Cardurion Pharmaceuticals, Inc.NCT06658899

~$75 – $2,800

Actual pay is set by the research site.

Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids in Varying Signal-to-Noise Conditions

This study is designed to understand how different hearing-aid noise-reduction technologies affect a listener's ability to hear speech in noisy environments. P…

Hearing Loss, Cochlear

Purdue UniversityNCT07287774

Actual pay is set by the research site.

Impact of Maternal Left-Lateral Recumbent Positioning in Pregnancies With Fetal Growth Restriction

The goal of this clinical trial is to learn if maternal left-lateral positioning in pregnancy works to treat fetal growth restriction. This study will also hel…

Fetal Growth Restriction

University of Colorado, DenverNCT06919692

Actual pay is set by the research site.

Parkinson's DiseaseSleep Fragmentation

Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers in Sleep Dysregulation and Repair

Parkinson's Disease (PD) is the second most common of the age-related neurodegenerative disorders, affecting over 1,900 adults per 100,000 over the age of 80 i…

University of NebraskaNCT05070013

Actual pay is set by the research site.

Anaplastic Large Cell Lymphoma, ALK-Positive

NYMC623: A Comprehensive Risk-adapted Chemommunotherapy Protocol of Emerging Immunotherapies for Relapsed/Refractory Alk+ Anaplastic Large Cell Lymphoma (ACCELERATE)

Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/R) high-risk ALK+ Anaplastic Large Cell Lymphoma (ALCL) have a low incidence of over…

New York Medical CollegeNCT07013565

~$75 – $2,000

Actual pay is set by the research site.

Multiple Sclerosis Implementation Network

The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas H…

Multiple Sclerosis

The University of Texas Health Science Center, HoustonNCT07415824

Actual pay is set by the research site.

Better Social, Emotional Communication, Healthy Relationship and ASD Accommodation Skills: Emotional Intelligence ("EQ") Training for Autistic People and ASD Accommodation Training for People Who Care

Subjects are enrolled in pairs. Pairs consist of an autistic adult age 18-36 and a non-autistic learning partner who has a relationship with the autistic adult…

Autism